| 000 | 01850 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515162918.0 | ||
| 264 | 0 | _c20090720 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1019-6439 | ||
| 024 | 7 |
_a10.3892/ijo_00000231 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAli, M Aktar | |
| 245 | 0 | 0 |
_aSNS-032 prevents hypoxia-mediated glioblastoma cell invasion by inhibiting hypoxia inducible factor-1alpha expression. _h[electronic resource] |
| 260 |
_bInternational journal of oncology _cApr 2009 |
||
| 300 |
_a1051-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCollagen _xchemistry |
| 650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aDNA Primers _xchemistry |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHypoxia |
| 650 | 0 | 4 |
_aHypoxia-Inducible Factor 1, alpha Subunit _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLaminin _xchemistry |
| 650 | 0 | 4 | _aMatrix Metalloproteinase Inhibitors |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 |
_aOxazoles _xpharmacology |
| 650 | 0 | 4 |
_aProteoglycans _xchemistry |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xmetabolism |
| 650 | 0 | 4 |
_aThiazoles _xpharmacology |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 700 | 1 | _aReis, Aimee | |
| 700 | 1 | _aDing, Liang-Hao | |
| 700 | 1 | _aStory, Michael D | |
| 700 | 1 | _aHabib, Amyn A | |
| 700 | 1 | _aChattopadhyay, Ansuman | |
| 700 | 1 | _aSaha, Debabrata | |
| 773 | 0 |
_tInternational journal of oncology _gvol. 34 _gno. 4 _gp. 1051-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/ijo_00000231 _zAvailable from publisher's website |
| 999 |
_c18726880 _d18726880 |
||